Uncategorized
VIDEO: President discusses the approval of Avastin in France
PARIS — At the meeting of the French Society of Ophthalmology, Jean Françoise Korobelnik, MD, President of the SFO, talks about the recent provisions of the French government in favor of Avastin, which will be allowed in public hospitals to treat patients with wet AMD. Issues remain concerning safe compounding, costs and criteria for assigning patients to be treated with Avastin, Lucentis or Eylea. A second government provision is the approval and funding of Argus II, which will be implanted in 36 selected patients.